chevron_leftBack
As of 24 April 2025, ChemoMetec A/S has a market cap of $1.27B USD, ranking #7106 globally and #38 in Denmark. It ranks #676 in the Healthcare sector, and #73 in the Medical Devices industry.
Key Stats
Market Cap
$1.27BUSD
8.35B DKK
Enterprise Value
$1.23BUSD
8.1B DKK
Revenue (TTM)
$70.05MUSD
459.54M DKK
EBITDA (TTM)
$33.53MUSD
219.98M DKK
Net Income (TTM)
$25.77MUSD
169.08M DKK
EBITDA Margin
48%
Profit Margin
37%
PE Ratio
49.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Martin Behrens
open_in_new
Employees
174
Founded
1997
Website
chemometec.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.2% | 0.8% | -9.9% | -5% | 12% | 65% |
Upcoming Earnings
Earnings Date
Wed, May 7
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
CHEMM
ChemoMetec AS
ISIN: DK0060055861
Shares Out.:
Shares Outstanding:
17.403M1
Shares Float:
16.771M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
474.40 DKK | |
|
0DZ0
ChemoMetec AS
ISIN: DK0060055861
|
480.20 DKK |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About ChemoMetec A/S
ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCounter SP-100, an automated sperm cell counter for use in animal reproduction; and XcytoMatic 40, a cell density and viability analyzer. In addition, the company provides consumables comprising cassettes, reagents, lysis, and slides; accessories, which include cables, power supplies, software, and labware products, as well as service and validation plans and training. Further, it develops as well as develops XcytoMatic 30 cell counter. ChemoMetec A/S was incorporated in 1997 and is headquartered in Allerød, Denmark.
